To Study the Function of the Retina in Glaucoma Patients Using PERG
A Prospective, Longitudinal Study to Evaluate the Function of the Retina and Visual Pathways in Glaucoma Patients Using PERG
Sponsor: Swiss Vision Network
A observational or N/A phase clinical study on Glaucoma, this trial is ongoing. The trial is conducted by Swiss Vision Network and has accumulated 9 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Jan 2026 — Present [monthly]
Unknown
-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jun 2024 — Jul 2024 [monthly]
Unknown Status
Status: Enrolling By Invitation → Unknown Status
-
Jun 2022 — Jun 2024 [monthly]
Enrolling By Invitation
Status: Unknown Status → Enrolling By Invitation
▶ Show 4 earlier versions
-
Jan 2021 — Jun 2022 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Jan 2021 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Recruiting NA
First recorded
Jan 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Swiss Vision Network
For direct contact, visit the study record on ClinicalTrials.gov .